Psilocybin Shows Temporary Symptom Reversal in Advanced Dementia Case Study

A single case study reports an 80-year-old woman with advanced dementia experienced significant, temporary symptom reversal following a large dose of psilocybin. The patient, who had been diagnosed with dementia ten years prior, showed improvements in mobility, continence, and communication.

Following a 5-gram dose of psilocybin, the patient exhibited a prolonged sleep-like state before initiating autobiographical conversation. Subsequent improvements included independent walking, self-dressing, and enhanced social interaction, which persisted for several weeks.

Ethical approval for this intervention was not required

Ethical approval for this intervention was not required, as it was conducted in routine private clinical practice under local legislation. This contrasts with established research protocols for high-dose psilocybin, which typically involve rigorous ethical board review.

Experts caution that this is an isolated case report, not a controlled study. The patient's diagnosis was not scientifically verified, and dementia symptoms can fluctuate naturally. The observed effects were temporary, and the study does not provide evidence of disease reversal.